Compare AbbVie Inc (ABBV) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs United States Natural Gas Fund — how do they compare? AbbVie Inc trades at $253.85 (market cap $449.91B), while United States Natural Gas Fund trades at $11.6. The key difference: AbbVie Inc pays a 2.72% dividend while United States Natural Gas Fund pays none, and AbbVie Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| ABBV | UNG | |
|---|---|---|
Market Cap | $449.91B | — |
Sector | Health | Commodities - Energy |
52-Week High | $261.07 | $16.90 |
52-Week Low | $184.85 | $10.15 |
Enterprise Value | $513.38B | — |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $254.44, showing slight daily weakness but maintaining a bullish technical structure with strong institutional support. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $2.65 exceeding the $2.59 estimate. Revenue growth is accelerating, reaching $61.16B in 2025, while the immunology portfolio (Skyrizi, Rinvoq) successfully offsets Humira declines. Analyst consensus remains strongly positive with 68% buy ratings and a $266.33 price target.
The outlook is constructive with robust pipeline developments and dividend growth, though elevated valuation multiples (P/E 124.83, P/B 245.29) and looming patent cliffs in the 2030s present risks. Net income margin compression from 20.38% in 2022 to 6.9% in 2025 requires monitoring, but strong cash generation ($19.03B operating cash flow) supports continued shareholder returns.
UNG trades at $11.71, up 1.12% today, with a bullish technical signal driven by moving averages. The fund tracks natural gas futures, with sentiment influenced by weather-driven demand and LNG export flows. Recent news highlights volatility from storage data and production forecasts, while technical indicators like RSI remain neutral.
Outlook hinges on natural gas price trends, with upside from demand spikes but risks from contango and ample supply. Investors face structural challenges, as noted in analysis citing decade-long losses, requiring caution despite short-term bullish signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
